Shareholder alert: pomerantz law firm investigates claims on behalf of investors of karyopharm therapeutics inc. - kpti

New york, new york--(newsfile corp. - january 18, 2023) - pomerantz llp is investigating claims on behalf of investors of karyopharm therapeutics inc. ("karyopharm" or the "company") (nasdaq: kpti). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.the investigation concerns whether karyopharm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
KPTI Ratings Summary
KPTI Quant Ranking